MASI - マシモ (Masimo Corporation) マシモ

 MASIのチャート


 MASIの企業情報

symbol MASI
会社名 Masimo Corp. (マシモ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Electromedical_Electrotherapeutic Apparatus  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 マシモ(Masimo Corporation) は医療技術企業であり、非侵襲患者モニタリング製品を開発・製造・販売する。同社の事業はマシモ信号抽出技術(SET)パルスオキシメトリーと知られる測定スルーモーションおよび低灌流パルスオキシメトリーモニタリングである。製品には光学特性、光学臓器酸素濃度測定、電気、脳機能モニタリング、音響呼吸モニタリング、呼気モニタリングなどの血液成分の非侵襲的モニタリングが含まれる。同社はまたRoot患者のモニタリングおよび接続プラットフォーム、Radical-7ベッドサイドとポータブル患者モニタ、Radius-7ウェアラブル無線患者モニタを開発する。同社はPatient SafetyNetリモート患者監視監視システムを提供する。これにより、患者はパーソナルコンピュータベースのモニタまたはポケベル、ボイスオーバーインターネットプロトコル(IP)電話、スマートフォンを通じてケア提供者によって監視される。   マシモは、米国の医療技術企業。非侵襲的患者監視製品を開発、製造、売買に従事する。患者監視ソリュ―ションは、一般的にはモニタ―や回路基板とセンサ―に組み込まれる。主にに直接パ―トナ―代理店もしくは元の機器メ―カ―を通じて、病院、救急医療サ―ビス・プロバイダ―、医師、獣医師、介護施設や消費者に同社製品を販売する。   Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.
本社所在地 52 Discovery Irvine CA 92618 USA
代表者氏名 Joseph E. Kiani ジョセフ・E・キアニ
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 949-297-7000
設立年月日 32629
市場名 NASDAQ National Market System
ipoyear 2007年
従業員数 4600人
url www.masimo.com
nasdaq_url https://www.nasdaq.com/symbol/masi
adr_tso
EBITDA EBITDA(百万ドル) 233.99600
終値(lastsale) 119.46
時価総額(marketcap) 6232234889.76
時価総額 時価総額(百万ドル) 650.162
売上高 売上高(百万ドル) 843.44700
企業価値(EV) 企業価値(EV)(百万ドル) 5620.515
当期純利益 当期純利益(百万ドル) 207.08600
決算概要 決算概要 BRIEF: For the 26 weeks ended 30 June 2018 Masimo Corporation revenues increased 9% to $424.6M. Net income decreased 7% to $89.5M. Revenues reflect United States segment increase of 10% to $281.2M Europe Middle East and Africa segment increase of 22% to $78.4M. Net income was offset by Selling general and administrative increase of 7% to $142.6M (expense) Research and development increase of 23% to $37.7M (expense).

 MASIのテクニカル分析


 MASIのニュース

   Masimo Clears Early Entry  2020/07/20 15:17:41 Yahoo Finance
Masimo rose above a 214.24 early entry, following a rebound from 10-week line last week. Conventional buy point is 258.10. Masimo did very well during the market crash, was an early breakout and has consolidated again.
   Masimo Announces Bridge™  2020/06/29 12:00:00 Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Bridge™, an opioid withdrawal solution, is the first evidence-based, drug-free, non-surgical device of its kind.
   Masimo Announces FDA Clearance of Centroid™  2020/06/25 20:49:00 Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Centroid™, a wearable, wireless patient orientation, activity, and respiration rate sensor, has received FDA clearance.
   Masimo Announces Masimo Sleep™, a New Wellness Solution That Allows Users to Better Understand Their Sleep Quality  2020/06/19 12:00:00 Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Sleep™ is designed to help consumers better understand the quality of their sleep and is available for pre-order today.
   Masimo Announces Masimo SafetyNet-Open™  2020/06/19 12:00:00 Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Masimo SafetyNet-Open™ is designed to help organizations more responsibly manage employee and student health and safety during COVID-19.
   Masimo Announces Masimo Sleep™, a New Wellness Solution That Allows Users to Better Understand Their Sleep Quality  2020/06/19 12:00:00 Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Sleep™ is designed to help consumers better understand the quality of their sleep and is available for pre-order today.
   Masimo Announces Masimo SafetyNet-Open™  2020/06/19 12:00:00 Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Masimo SafetyNet-Open™ is designed to help organizations more responsibly manage employee and student health and safety during COVID-19.
   Masimo (MASI) Gains But Lags Market: What You Should Know  2020/06/05 21:50:08 Zacks Investment Research
Masimo (MASI) closed the most recent trading day at $220.24, moving +0.75% from the previous trading session.
   Why Is Masimo (MASI) Up 5.3% Since Last Earnings Report?  2020/05/28 15:31:06 Zacks Investment Research
Masimo (MASI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Development of Smart and Wireless Oximeters and Spirometers, Reports TBRC  2020/05/21 15:30:00 Benzinga Feeds
LONDON , May 21, 2020 /PRNewswire/ -- Companies in the pulse oximeters and spirometer market are increasingly focusing on developing smart and wireless oximeters and spirometers. Use of wireless technology in monitoring devices is an emerging trend, which enhances its ease of usage and data analysis. The integration of wireless technology allows the transfer of data from the device to a smart phone or a wireless device, through Bluetooth or cellular connection for data processing, and then to display the results. In 2018, the US Food and Drug Administration approved Masimo MightySat Rx Fingertip Pulse Oximeter by Masimo Corporation, and Smart One by MIR. In 2019, the Loop system by Spry Health, Inc., and B.O.L.T. by American Megatrends India Private Limited were approved, which are used to monitor vital parameters and respiratory parameters. The intermittent data collected by the Loop System is transferred to the clinician by web server, data communication by Smart One and Masimo MightySat Rx Fingertip Pulse Oximeter are done through Bluetooth pairing, and B.O.L.T. is operated by a connection with Bluetooth enabled smart devices.
   Here's Why Investors Should Buy Masimo (MASI) Stock Now  2020/03/24 08:51:00 Zacks Investment Research
Masimo (MASI) sees a slew of developments lately.
   Masimo & University Hospitals Unite for Patient Monitoring  2020/03/24 08:49:00 Zacks Investment Research
Masimo (MASI) sees a plethora of developments lately.
   In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow® Noninvasive Blood Constituent Monitoring, Including Total Hemoglobin, SpHb®, at No Additional Charge During the Coronavirus Pandemic  2020/03/23 12:00:00 Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Masimo is offering rainbow® licenses to hospitals with rainbow®-ready devices at no additional charge upon the purchase of RD rainbow® sensors.
   Why Is Masimo (MASI) Down 9.6% Since Last Earnings Report?  2020/03/20 15:30:41 Zacks Investment Research
Masimo (MASI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Masimo's Latest Buyout to Boost Respiratory Product Spectrum  2020/03/20 13:04:00 Zacks Investment Research
Masimo (MASI) expects the transaction to be neutral to 2020 earnings.

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 マシモ MASI Masimo Corporation)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)